Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBig Yellow Regulatory News (BYG)

Share Price Information for Big Yellow (BYG)

Share Price is delayed by 15 minutes
Get Live Data
872.50    2.00 (0.23%)
Bid:
871.50
Ask:
872.50
Spread: 1.00 (0.115%)
Market Cap: £1.71b
BYG Live PriceLast checked at - London Stock Exchange

Intraday Big Yellow Share Chart

Form 8.3 - Big Yellow Group plc

16 Oct 2025 13:09

RNS Number : 7081D
Aberdeen Group PLC
16 October 2025
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Aberdeen Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Big Yellow Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

15 October 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

10p ordinary

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

2,224,658

1.13

Β 

Β 

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

TOTAL:

2,224,658

1.13

Β 

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

10p ordinary

Sale

6,525

GBP 11.200

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

No

Β 

Β 

Date of disclosure:

16 October 2025

Contact name:

Jenny Clarke

Telephone number*:

+44 131 372 9159

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETEAAEKFEPSFFA
Date   Source Headline
2nd May 20247:00 amRNSNotification of Full Year Results
30th Apr 20243:57 pmRNSTotal Voting Rights
5th Apr 20242:24 pmRNSTotal Voting Rights
13th Mar 20242:14 pmRNSDirector/PDMR Shareholding
29th Feb 20249:45 amRNSTotal Voting Rights
31st Jan 20249:06 amRNSTotal Voting Rights
11th Jan 20247:00 amRNSTrading Statement
10th Jan 20247:00 amRNSNotification for Q3 results
29th Dec 202310:00 amRNSTotal Voting Rights
19th Dec 20237:00 amRNSRefinancing of revolving credit facility
12th Dec 20237:00 amRNSPlanning Update
8th Dec 20239:00 amRNSBlock Listing Of Shares
1st Dec 20232:10 pmRNSTotal Voting Rights
20th Nov 20234:35 pmRNSResults for the Six Months ended 30 September 2023
7th Nov 20237:00 amRNSNotification of Half Year Results
31st Oct 202311:07 amRNSTotal Voting Rights
11th Oct 202310:44 amRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSResults of Capital Raise
10th Oct 20234:43 pmRNSPrimaryBid Offer
10th Oct 20234:36 pmRNSProposed Capital Raise
2nd Oct 202310:24 amRNSBlock Listing Return
2nd Oct 20239:00 amRNSTotal Voting Rights
1st Sep 20239:17 amRNSTotal Voting Rights
29th Aug 20237:00 amRNSPlanning Update
10th Aug 202312:31 pmRNSHolding(s) in Company
4th Aug 20239:00 amRNSBlock Listing Of Shares
31st Jul 20239:47 amRNSTotal Voting Rights
20th Jul 20232:20 pmRNSDirector/PDMR Shareholding
20th Jul 20232:20 pmRNSDirector/PDMR Shareholding
20th Jul 20232:05 pmRNSResult of AGM
10th Jul 20237:00 amRNSQ1 Trading Statement
6th Jul 20237:00 amRNSNotification of Q1 statement
30th Jun 202310:11 amRNSTotal Voting Rights
20th Jun 20239:17 amRNSPublication of 2023 Annual Report & Notice of AGM
31st May 20239:11 amRNSTotal Voting Rights
22nd May 20234:35 pmRNSRESULTS FOR THE YEAR ENDED 31 MARCH 2023
3rd May 20237:00 amRNSNotice of Results
2nd May 20239:22 amRNSTotal Voting Rights
3rd Apr 20239:01 amRNSBlock Listing Return
3rd Apr 20239:00 amRNSTotal Voting Rights
28th Feb 20239:31 amRNSTotal Voting Rights
1st Feb 20239:26 amRNSTotal Voting Rights
12th Jan 20237:00 amRNSTrading Statement
10th Jan 20237:00 amRNSNotice of Results
30th Dec 20229:00 amRNSTotal Voting Rights
30th Nov 202210:00 amRNSTotal Voting Rights
21st Nov 20224:35 pmRNSResults for the Six Months ended 30 September 2022
17th Nov 20229:00 amRNSBlock Listing Of Shares
1st Nov 20229:30 amRNSTotal Voting Rights
1st Nov 20227:00 amRNSNotification of Half Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.